Delivery Order SPE2DB20D3103-SPE2DB23FP9C8
Award Date
9/27/23
Potential Completion Date
10/19/23
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA), a major procurement agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., a major pharmaceutical distribution firm. The contract, valued at $5,687.28, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical. This IDC,...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The specific award is a $3,230.68 firm...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets, a pharmaceutical product, to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for a Firm Fixed Price of $3,230.68. The contract has an ultimate completion date of August 5, 2024 and was awarded on July 15, 2024. This award is a Delivery Order issued under Amerisourcebergen's...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The $4,845.99 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 4, 2024 and was awarded on November 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award is for the provision of Envarsus XR 1 mg tablets to the Defense Logistics Agency (DLA). The $1,288.86 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of February 19, 2025 and was awarded on January 28, 2025. No set-aside designation was used for this award. The contract is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The $6,461.32 firm-fixed price contract was awarded on April 24, 2024 to AmerisourceBergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, with a period of performance through May 15, 2024. The contract is not designated as a set-aside and was awarded under a larger Indefinite Delivery...
This federal contract award is for the delivery of Envarsus XR 4 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $9,391.86, with a firm fixed price. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This...
This federal contract award is for the delivery of Envarsus XR 0.75 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024, with a ceiling value of $1,216.48 and a completion date of August 14, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen has been awarded numerous federal contracts by various agencies, including a...
This federal contract award, valued at $4,027.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Envarsus XR 1 mg tablets, a specialty medication. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award was made by the Department of Defense (DoD) Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to supply the drug Envarsus XR 1 mg Tablet. The contract has a ceiling value of $1,216.11 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the Defense Logistics Agency (DLA) Troop Support Medical. This IDC serves as the primary vehicle for...